Trifecta Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4
Closed -$367 – 343
2026
Q2
$367 Buy
+4
New +$350 ﹤0.01% 435
2025
Q4
– Sell
-18
Closed -$1.44K – 295
2025
Q3
$1.44K Sell
18
-43
-70% -$3.67K ﹤0.01% 378
2025
Q2
$5.54K Buy
61
+43
+239% +$3.93K ﹤0.01% 263
2025
Q1
$1.69K Hold
18
– – ﹤0.01% 328
2024
Q4
$1.64K Hold
18
– – ﹤0.01% 324
2024
Q3
$1.87K Sell
18
-190
-91% -$19.4K ﹤0.01% 318
2024
Q2
$20.2K Buy
208
+190
+1,056% +$17.5K ﹤0.01% 190
2024
Q1
$1.62K Hold
18
– – ﹤0.01% 327
2023
Q4
$1.44K Hold
18
– – ﹤0.01% 358
2023
Q3
$1.28K Hold
18
– – ﹤0.01% 352
2023
Q2
$1.39K Hold
18
– – ﹤0.01% 345
2023
Q1
$1.35K Hold
18
– – ﹤0.01% 346
2022
Q4
$1.42K Buy
+18
New +$1.35K ﹤0.01% 348

Other funds holding CL

Trifecta Capital Advisors's CL Position: Q3 2026 in Review

Trifecta Capital Advisors sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 4 shares — an estimated $367 sold.

Trifecta Capital Advisors first reported a position in CL in Q4 2022 and held it in 13 quarters. The position peaked at $20.2K in Q2 2024. 808 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Trifecta Capital Advisors reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Trifecta Capital Advisors sold 4 Colgate-Palmolive shares in Q3 2026, an estimated $367.
  • Trifecta Capital Advisors first reported a position in Colgate-Palmolive in Q4 2022 and held it in 13 quarters.
  • Trifecta Capital Advisors's Colgate-Palmolive position peaked at $20.2K in Q2 2024.
  • 808 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.